Rodent models for anticancer toxicity studies: Contributions to drug development and future perspectives

Drug Discov Today. 2023 Jul;28(7):103626. doi: 10.1016/j.drudis.2023.103626. Epub 2023 May 22.

Abstract

Antineoplastic treatment induces a type of gastrointestinal toxicity known as mucositis. Findings in animal models are usually easily reproducible, and standardized treatment regimens are often used, thus supporting translational science. Essential characteristics of mucositis, including intestinal permeability, inflammation, immune and oxidative responses, and tissue repair mechanisms, can be easily investigated in these models. Given the effects of mucositis on the quality of life of patients with cancer, and the importance of experimental models in the development of more effective new therapeutic alternatives, this review discusses progress and current challenges in using experimental models of mucositis in translational pharmacology research.

Keywords: alternative models; antineoplastic toxicity; gastrointestinal mucositis; rodent models; translational research.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / toxicity
  • Drug Development
  • Intestinal Mucosa
  • Mucositis* / chemically induced
  • Mucositis* / drug therapy
  • Quality of Life
  • Rodentia

Substances

  • Antineoplastic Agents